What have we done so far and how much more should we do? What are our expectations and how attainable are they? This is just a clip from our 2017 Symposium “New Horizons in Liver Disease“ programme, which will take place during the International Liver Congress™ in Amsterdam, on Thursday, 20th April 2017 from 16:00 – 18:00.
Although there has been remarkable progress, liver disease as a whole still represents a growing concern for Europe, where an estimated
29 million EU citizens suffer from a chronic liver condition. Chronic Viral Hepatitis B is the second major cause of both cirrhosis and liver cancer, Chronic Hepatitis C is an important risk factor for hepatocellular carcinoma, non-alcoholic fatty liver disease is a major concern given the growing incidence of obesity in Europe. Finally, for unknown reasons autoimmune liver diseases such as PBC, PSC and autoimmune hepatitis seem to be on the rise as well and overshadow lives not only because of the liver disease itself, but also because of a mulitutde of symptoms.
At the ELPA symposium, we want to look specifically at what progress has been made, and what the future looks like, for Hepatitis B, Hepatitis C, Autoimmune Liver Diseases such as PBC, PSC and autoimmune hepatitis, and NAFLD & NASH. In addition, the symposium provides us with an opportunity to showcase the work ELPA has carried out in the last year, in particular, the information from our Hep-CORE survey, and also to look at our wish list what progress we would like to see in the next 20 years of hepatology. We are once again pleased to welcome experts who will shed light on the current situation, and also explain what this means from a patient’s perspective. At the end of the presentations, participants fromthe audience as well as speakers are invited to join our panel discussion.
Please register via email for the ELPA Symposium at: firstname.lastname@example.org
Registration to the EASL International Liver Congress will be necessary to enter the RAI Amsterdam.
Our symposium is open to all attending ILC.
Learn more about ELPA 2017 Symposium programme here.